Panacea Biotec Ltd - Company Profile
Powered by 
All the data and insights you need on Panacea Biotec Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Panacea Biotec Ltd Strategy Report
- Understand Panacea Biotec Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Panacea Biotec Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 15 May 2023 | Panacea Biotec Ltd Enters Phase II/III Clinical Trial Agreement with Clinical Research Network India for (diphtheria + tetanus) vaccine (GDCT0487324) | Contract Service Agreement |
Panacea Biotec Ltd
|
Clinical Research Network India
|
| 28 Feb 2022 | Mankind Pharma to Acquire Formulation Brands from Panacea Biotec Pharma | Asset Transaction |
Mankind Pharma Ltd
|
Panacea Biotec Ltd |
| 17 May 2021 | Serum Institute of India (SII) Acquires 5.15% Stake in Panacea Biotec | Acquisition |
Serum Institute of India Pvt Ltd
|
Panacea Biotec Ltd |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer